Rockwell Medical Financials
| RMTI Stock | USD 1.48 0.01 0.67% |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.62 | 1.7293 |
|
|
The financial analysis of Rockwell Medical is a critical element in measuring its lifeblood. The essential information of the day-to-day investment outlook for Rockwell Medical includes many different criteria found on its balance sheet. For example, investors should never minimize Rockwell Medical's ability to pay suppliers or employees on time, making sure interest payments are not accumulating or correctly timing where and how to re-invest extra cash. Any individual investor needs to monitor Rockwell Medical's cash flow, debt, and profitability to effectively and accurately make more informed decisions on whether to invest in Rockwell Medical.
Net Income |
|
With this module, you can analyze Rockwell financials for your investing period. You should be able to track the changes in Rockwell Medical individual financial statements over time to develop the understanding of its risk, liquidity, profitability, or other critical and vital indicators.
Rockwell | Select Account or Indicator |
Understanding current and past Rockwell Medical Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Rockwell Medical's financial statements are interrelated, with each one affecting the others. For example, an increase in Rockwell Medical's assets may result in an increase in income on the income statement.
The data published in Rockwell Medical's official financial statements usually reflect Rockwell Medical's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Rockwell Medical. For example, before you start analyzing numbers published by Rockwell accountants, it's critical to develop an understanding of what Rockwell Medical's liquidity, profitability, and earnings quality are in the context of the Health Care Equipment & Supplies space in which it operates.
Please note, the presentation of Rockwell Medical's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Rockwell Medical's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Rockwell Medical's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Rockwell Medical. Please utilize our Beneish M Score to check the likelihood of Rockwell Medical's management manipulating its earnings.
Rockwell Medical Stock Summary
Rockwell Medical competes with Neurocrine Biosciences, Deciphera Pharmaceuticals, Ironwood Pharmaceuticals, Alkermes Plc, and Avadel Pharmaceuticals. Rockwell Medical, Inc., together with its subsidiaries, operates as a biopharmaceutical company that targets end-stage renal disease and chronic kidney disease with therapies and products for the treatment of iron deficiency and hemodialysis in the United States and internationally. Rockwell Medical, Inc. was incorporated in 1996 and is headquartered in Wixom, Michigan. Rockwell Medical operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on NASDAQ Exchange. It employs 300 people.Specialization | Health Care, Drug Manufacturers - Specialty & Generic |
| Instrument | USA Stock View All |
| Exchange | NASDAQ Exchange |
| ISIN | US7743741024 |
| CUSIP | 774374102 774374300 |
| Location | New Jersey; U.S.A |
| Business Address | 30142 South Wixom |
| Sector | Health Care Equipment & Supplies |
| Industry | Health Care |
| Benchmark | NYSE Composite |
| Website | www.rockwellmed.com |
| Phone | 248 960 9009 |
| Currency | USD - US Dollar |
You should never invest in Rockwell Medical without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Rockwell Stock, because this is throwing your money away. Analyzing the key information contained in Rockwell Medical's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Rockwell Medical Key Financial Ratios
Generally speaking, Rockwell Medical's financial ratios allow both analysts and investors to convert raw data from Rockwell Medical's financial statements into concise, actionable information that can be used to evaluate the performance of Rockwell Medical over time and compare it to other companies across industries. There are many critical financial ratios that investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Rockwell Medical reports annually and quarterly.| Return On Equity | -0.48 | ||||
| Profit Margin | (0.10) % | ||||
| Operating Margin | (0.02) % |
Rockwell Medical Key Balance Sheet Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Total Assets | 44.3M | 77.7M | 48.6M | 46.6M | 52.2M | 37.3M | |
| Other Current Liab | 4.8M | 5.1M | 5.1M | 7.7M | 9.9M | 10.4M | |
| Net Debt | (7.8M) | (24.7M) | 15.6M | (5.1M) | 4.5M | 4.7M | |
| Retained Earnings | (306.5M) | (337.4M) | (370.1M) | (388.8M) | (397.2M) | (377.3M) | |
| Accounts Payable | 3.0M | 4.2M | 3.7M | 4.1M | 4.5M | 4.1M | |
| Cash | 11.8M | 48.7M | 13.3M | 21.5M | 9.0M | 13.5M | |
| Net Receivables | 4.2M | 4.2M | 5.9M | 6.3M | 10.9M | 11.4M | |
| Inventory | 3.6M | 3.9M | 4.1M | 5.8M | 5.9M | 3.8M | |
| Other Current Assets | 3.0M | 2.7M | 2.9M | 1.7M | 1.1M | 1.1M | |
| Total Liab | 24.0M | 43.6M | 46.0M | 32.5M | 30.9M | 18.1M | |
| Total Current Assets | 36.9M | 69.5M | 35.3M | 35.3M | 28.8M | 31.1M | |
| Short Term Debt | 2.3M | 1.2M | 9.8M | 4.1M | 2.2M | 1.8M | |
| Common Stock | 299.6M | 6.5K | 9K | 1K | 3K | 2.9K | |
| Intangible Assets | 4.0K | 3.7K | 3.3K | 10.8M | 12.4M | 13.0M | |
| Other Assets | 875.9K | 4.7M | 2.1M | 13.8M | 15.9M | 16.7M | |
| Net Tangible Assets | 19.4M | 33.2M | 1.6M | 13.2M | 11.9M | 20.7M | |
| Other Liab | 9.8M | 8.0M | 6M | 2.6M | 2.4M | 2.2M |
Rockwell Medical Key Income Statement Accounts
An income statement is very similar to a cash flow statement, but instead of showing net revenue minus expenses, it only includes earnings before interest and taxes (EBIT). This number does not have all of the same line items that are on a cash flow statement, but it leaves out non-cash expenses like depreciation and amortization. For example, if you bought $100 worth of goods from Walmart (WMT) using your debit card that has an interest rate of 20%, then paid off the balance at the end of the month with a credit card that charges 30% interest, you would have an income statement showing EBIT of $80 because your expenses are lower than the amount that went into your pocket. The other reason investors look at the income statement is to determine what Rockwell Medical's earnings per share (EPS) will be in order to see if they want to buy more shares or not. For example, if a company earned $20 million in the last quarter and has 100,000 shares outstanding, its EPS is 20 cents. If you find that this number beats analysts' forecasts or is higher than it was from the same period last year, then you might want to buy more of this stock even though its price per share may not have changed.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Total Revenue | 61.3M | 62.2M | 61.9M | 72.8M | 83.6M | 45.6M | |
| Gross Profit | 2.8M | 2.7M | (2.4M) | 4.1M | 8.7M | 9.1M | |
| Operating Income | (34.1M) | (28.4M) | (30.3M) | (16.8M) | (6.7M) | (7.0M) | |
| Ebit | (34.1M) | (28.4M) | (30.3M) | (16.8M) | (6.7M) | (7.0M) | |
| Ebitda | (34.1M) | (26.7M) | (27.8M) | (16.7M) | (5.2M) | (5.5M) | |
| Cost Of Revenue | 58.5M | 59.5M | 64.4M | 68.7M | 74.9M | 41.4M | |
| Net Income | (31.1M) | (31.9M) | (35.0M) | (20.6M) | (8.4M) | (8.9M) | |
| Income Tax Expense | (3.0M) | 1.0M | 2.4M | 1.9M | 2.2M | 2.3M | |
| Income Before Tax | (34.1M) | (30.9M) | (32.7M) | (18.7M) | (8.4M) | (8.9M) | |
| Research Development | 6.9M | 7.1M | 6.8M | 3.1M | 1.1M | 1.1M | |
| Interest Income | 367.1K | 238K | 22K | 33K | 211K | 257.7K | |
| Net Interest Income | 367.1K | (1.6M) | (2.3M) | (1.9M) | (1.4M) | (1.3M) |
Rockwell Medical Key Cash Accounts
Cash flow analysis captures how much money flows into and out of Rockwell Medical. It measures of how well Rockwell is doing because it can show the actual money that comes into and out of the Company from sales instead of measuring expenses against revenue to determine earnings. You have to read the cash flow statement in three sections. The first section shows how much money Rockwell Medical brought in, usually known as net revenue or sales. This is different from earnings because it does not include expenses when determining net revenue for use on this part of the cash flow statement. Next, are operating activities, which show how much money Rockwell had leftover after paying for its expenses. This number can be calculated in two ways: by subtracting the total of all operating expenses from net revenue or by adding up changes to cash and other assets or liabilities on this part of the statement. The third section is about investing activities, which shows what Rockwell Medical has done with the money that it received from the sale of assets or what it spent to acquire new ones. This section can be broken down into two parts: investing in existing businesses (in other words, buying more stock) and investing in non-business activities like paying off debt or making acquisitions.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Change In Cash | (10.9M) | 36.9M | (35.4M) | (3.2M) | (1.1M) | (1.1M) | |
| Free Cash Flow | (28.6M) | (30.7M) | (34.1M) | (17.7M) | (22.1M) | (21.0M) | |
| Depreciation | 2.7M | 2.3M | 2.5M | 2.6M | 1.4M | 1.1M | |
| Other Non Cash Items | 1.2M | 294K | 369K | 969K | 6.9M | 7.2M | |
| Capital Expenditures | 1.3M | 1.0M | 522K | 281K | 12.6M | 13.3M | |
| Net Income | (34.1M) | (30.9M) | (32.7M) | (18.7M) | (8.4M) | (8.9M) | |
| End Period Cash Flow | 11.8M | 48.7M | 13.3M | 10.1M | 9.0M | 13.2M | |
| Change To Inventory | 316.9K | (1.3M) | (656K) | (2.1M) | 1.2M | 1.2M | |
| Investments | 38.3M | 4.3M | 311K | (2.4M) | (1.8M) | (1.7M) | |
| Change To Netincome | 6.2M | 1.6M | 1.1M | 915K | 823.5K | 782.3K |
Rockwell Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Rockwell Medical's current stock value. Our valuation model uses many indicators to compare Rockwell Medical value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Rockwell Medical competition to find correlations between indicators driving Rockwell Medical's intrinsic value. More Info.Rockwell Medical is rated below average in return on equity category among related companies. It is rated below average in return on asset category among related companies . As of now, Rockwell Medical's Return On Equity is increasing as compared to previous years.Comparative valuation analysis is a catch-all model that can be used if you cannot value Rockwell Medical by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Rockwell Medical's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Rockwell Medical's earnings, one of the primary drivers of an investment's value.Rockwell Medical Systematic Risk
Rockwell Medical's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Rockwell Medical volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was fifty with a total number of output elements of eleven. The Beta measures systematic risk based on how returns on Rockwell Medical correlated with the market. If Beta is less than 0 Rockwell Medical generally moves in the opposite direction as compared to the market. If Rockwell Medical Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Rockwell Medical is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Rockwell Medical is generally in the same direction as the market. If Beta > 1 Rockwell Medical moves generally in the same direction as, but more than the movement of the benchmark.
About Rockwell Medical Financials
What exactly are Rockwell Medical Financials? Typically, a company's financial statements are the reports that show the financial position of the company. Three primary documents fall into the category of financial statements. These documents include Rockwell Medical's income statement, its balance sheet, and the statement of cash flows. Potential Rockwell Medical investors and stakeholders use financial statements to determine how well the company is positioned to perform in the future. Although Rockwell Medical investors may use each financial statement separately, they are all related. The changes in Rockwell Medical's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Rockwell Medical's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.Steps to analyze Rockwell Medical Financials for Investing
There are several different ways that investors can use financial statements to try and predict whether a stock price will go up or down. Unfortunately, there is no surefire formula, but there are some general guidelines you should consider when looking at the numbers. First, realize what kind of company it is so you know if its revenues are more likely to grow or shrink over time. For example, a software company's revenue is expected to increase yearly due to new products and services that its customers will want to buy. At the same time, a car manufacturer might not be able to sell as many cars when the economy slows down, so it would have less net income during those times. Second, pay attention to its debt-to-equity ratio because this number will tell you how much risk it has. If a company such as Rockwell Medical is not taking on any additional risks, its debt-to-equity should be less than one. As a general rule of thumb, if the market value or book value (which can be found in the footnotes) of assets exceeds the company's liabilities, then it is probably in good shape. Finally, use other financial statements to determine if a stock price will go up or down because investors are always looking for growth opportunities when they buy new stocks. For example, if you see that the net revenue of Rockwell has grown by more than 25% over the last five years, then there is a good chance that it will continue growing by at least 20% or more each year. On the other hand, if you see that net revenue has only increased by about 15%, which is barely above inflation levels, then chances are it will not grow much faster than this over time, and investors may shy away from buying it. In summary, you can determine if Rockwell Medical's financials are consistent with your investment objective using the following steps:- Review Rockwell Medical's balance sheet accounts, such as liabilities and equity, to understand its overall financial position.
- Analyze the income statement and examine the company's revenue, expenses, and profits over time to determine its financial performance.
- Study the cash flow inflows and outflows to understand Rockwell Medical's liquidity and solvency.
- Look at the growth rates in revenue, earnings, and cash flow over time to determine its potential for future growth.
- Compare Rockwell Medical's financials to those of its peers to see how it stacks up and identify any potential red flags.
- Use valuation ratios to evaluate the company's financials using commonly used ratios such as the price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and enterprise value-to-earnings before interest, taxes, depreciation, and amortization (EV/EBITDA) ratio to determine if Rockwell Medical's stock is overvalued or undervalued.
Today, most investors in Rockwell Medical Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Rockwell Medical's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Rockwell Medical growth as a starting point in their analysis.
Price Earnings To Growth Ratio |
|
Rockwell Medical April 19, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Rockwell Medical help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Rockwell Medical. We use our internally-developed statistical techniques to arrive at the intrinsic value of Rockwell Medical based on widely used predictive technical indicators. In general, we focus on analyzing Rockwell Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Rockwell Medical's daily price indicators and compare them against related drivers.
| Downside Deviation | 3.84 | |||
| Information Ratio | (0.01) | |||
| Maximum Drawdown | 24.9 | |||
| Value At Risk | (6.49) | |||
| Potential Upside | 8.73 |
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Rockwell Medical. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate. For more detail on how to invest in Rockwell Stock please use our How to Invest in Rockwell Medical guide.You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Complementary Tools for Rockwell Stock analysis
When running Rockwell Medical's price analysis, check to measure Rockwell Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Rockwell Medical is operating at the current time. Most of Rockwell Medical's value examination focuses on studying past and present price action to predict the probability of Rockwell Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Rockwell Medical's price. Additionally, you may evaluate how the addition of Rockwell Medical to your portfolios can decrease your overall portfolio volatility.
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. |
Is Rockwell Medical's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Rockwell Medical. If investors know Rockwell will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Rockwell Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.37) | Revenue Per Share 3.585 | Quarterly Revenue Growth 0.144 | Return On Assets (0.08) | Return On Equity (0.48) |
The market value of Rockwell Medical is measured differently than its book value, which is the value of Rockwell that is recorded on the company's balance sheet. Investors also form their own opinion of Rockwell Medical's value that differs from its market value or its book value, called intrinsic value, which is Rockwell Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Rockwell Medical's market value can be influenced by many factors that don't directly affect Rockwell Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Rockwell Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Rockwell Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Rockwell Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.